C19

C19 (also known as C19.ai) is a New York-based health intelligence company founded in 2019 by Gaurav Singal, the former Chief Data Officer of Foundation Medicine. The company leverages a proprietary artificial intelligence and data platform to accelerate the development of precision medicines and improve patient outcomes, with a primary focus on oncology and infectious diseases. During the COVID-19 pandemic, C19 gained prominence for its rapid response efforts, utilizing its platform to integrate genetic, clinical, and molecular data to identify potential therapeutic paths and support public health decision-making. The company operates as a technology-enabled biotech, partnering with pharmaceutical firms and academic institutions to structure complex clinical data and generate community-derived research hypotheses. C19's mission is to provide a unified infrastructure for deep modeling and analysis that bridges the gap between disparate health data sources and actionable medical insights.